Testing effectiveness (Phase 2)Active Not RecruitingNCT03971461
What this trial is testing
Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma
Who this might be right for
Meningioma
NYU Langone Health 32
Showing 20 of 0 results